May 14 (Reuters) - Athenex Inc ATNX.O :
* COMPANY HAS SUFFICIENT RESOURCES TO SUPPORT ATHENEX PHARMA
SOLUTIONS OPERATIONS AND FULFILL APD CUSTOMER ORDERS DURING
PROCESS
* COMPANY VOLUNTARILY FILES CHAPTER 11 PROCEEDINGS
* HAS REACHED AGREEMENT WITH LENDERS FOR SALE OF CO'S ASSETS
ACROSS ATHENEX PHARMACEUTICAL DIVISION, ORASCOVERY, CELL THERAPY
* COMPANY ANTICIPATES CONCLUDING EXPEDITED SALES PROCESS BY
JULY
1, 2023
* ATHENEX PHARMA SOLUTIONS IS EXPECTED TO CONTINUE ITS
OPERATIONS
FOR AT LEAST NEXT 90 DAYS
Source text for Eikon: urn:newsml:reuters.com:*:nGNX1QDj4b
Further company coverage: ATNX.O
((Reuters.Briefs@thomsonreuters.com;))